Related Experiment Video
Updated: Jun 16, 2026

A Protein Microarray Assay for Serological Determination of Antigen-specific Antibody Responses Following Clostridium difficile Infection
Published on: June 15, 2018
Detection and risk factor analysis of Clostridioides difficile infection in patients with malignant tumours
Limin Guo1, Zhen Zhang1, Xianqin Cao1
1Department of Clinical Laboratory, Xinxiang Central Hospital, The Fourth Clinical College of Xinxiang Medical College, Xinxiang, Henan, 453000, China; Xinxiang Key Laboratory of Respiratory Diseases, Xinxiang, Henan, 453000, China.
Objective:
To identify risk factors for Clostridioides difficile infection (CDI) in patients with malignant tumours and establish a predictive model for clinical prevention and early intervention.
Methods:
This retrospective study included 92 patients with malignant tumours (46 CDI-positive, 46 CDI-negative) admitted to our hospital. Demographic characteristics, clinical parameters, laboratory indicators and treatment factors were collected and analyzed. Univariate and multivariate logistic regression analyses were performed to identify independent risk factors for CDI, and a predictive model was established and evaluated using receiver operating characteristic curve analysis.
Results:
Patients with CDI had significantly lower serum albumin levels (30.12 ± 5.86 vs 34.15 ± 7.88 g/L, P = 0.007) and higher C-reactive protein (CRP) levels (89.38 ± 91.01 vs 49.17 ± 51.78 mg/L, P = 0.011) than patients without CDI. The CDI-positive group had significantly higher rates of multiple antibiotic use (52.2 % vs 10.9 %, P < 0.001) and corticosteroid/immunosuppressant use (58.7 % vs 30.4 %, P = 0.007) than the CDI-negative group. Multivariate logistic regression analysis identified four independent risk factors for CDI: multiple antibiotic use (odds ratio [OR] = 7.56, 95 % confidence interval [CI]: 2.41-23.73, P < 0.001), corticosteroid/immunosuppressant use (OR = 2.81, 95 % CI: 1.08-7.32, P = 0.035), serum albumin (per g/L increase: OR = 0.94, 95 % CI: 0.88-1.00, P = 0.049) and CRP (per mg/L increase: OR = 1.01, 95 % CI: 1.00-1.01, P = 0.047). The multivariate predictive model demonstrated excellent discriminative ability (area under the curve = 0.907).
Conclusion:
Multiple antibiotic use, corticosteroid/immunosuppressant therapy, hypoalbuminaemia and elevated CRP are independent risk factors for CDI in patients with malignant tumours. The predictive model established in this study may help identify patients at high risk who could benefit from preventive interventions.
Related Concept Videos
Hazard Ratio
For example, in a clinical trial evaluating a...
Cancer Survival Analysis
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Comparing the Survival Analysis of Two or More Groups

